Molecular Partners AG

SWX:MOLN Rapporto sulle azioni

Cap. di mercato: CHF 146.1m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Molecular Partners Crescita futura

Future criteri di controllo 2/6

Si prevede che gli utili di Molecular Partners diminuiranno a 2.1% all'anno, mentre si prevede che i suoi ricavi annuali cresceranno a 51.3% all'anno. Si prevede che l'EPS crescerà di 0.1% all'anno. Si prevede che il ritorno sul capitale proprio sarà -93.4% in 3 anni.

Informazioni chiave

-2.1%

Tasso di crescita degli utili

0.1%

Tasso di crescita dell'EPS

Biotechs crescita degli utili35.4%
Tasso di crescita dei ricavi53.0%
Rendimento futuro del capitale proprio-93.4%
Copertura analitica

Low

Ultimo aggiornamento28 Aug 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

We're Keeping An Eye On Molecular Partners' (VTX:MOLN) Cash Burn Rate

Sep 10
We're Keeping An Eye On Molecular Partners' (VTX:MOLN) Cash Burn Rate

We Think Some Shareholders May Hesitate To Increase Molecular Partners AG's (VTX:MOLN) CEO Compensation

Apr 11
We Think Some Shareholders May Hesitate To Increase Molecular Partners AG's (VTX:MOLN) CEO Compensation

Is Molecular Partners (VTX:MOLN) In A Good Position To Invest In Growth?

Jan 09
Is Molecular Partners (VTX:MOLN) In A Good Position To Invest In Growth?

Here's Why We're Watching Molecular Partners' (VTX:MOLN) Cash Burn Situation

Sep 08
Here's Why We're Watching Molecular Partners' (VTX:MOLN) Cash Burn Situation

Need To Know: The Consensus Just Cut Its Molecular Partners AG (VTX:MOLN) Estimates For 2023

Jun 23
Need To Know: The Consensus Just Cut Its Molecular Partners AG (VTX:MOLN) Estimates For 2023

What You Need To Know About The Molecular Partners AG (VTX:MOLN) Analyst Downgrade Today

Aug 31
What You Need To Know About The Molecular Partners AG (VTX:MOLN) Analyst Downgrade Today

Molecular Partners (VTX:MOLN) Is In A Good Position To Deliver On Growth Plans

May 09
Molecular Partners (VTX:MOLN) Is In A Good Position To Deliver On Growth Plans

Upgrade: Analysts Just Made A Substantial Increase To Their Molecular Partners AG (VTX:MOLN) Forecasts

Dec 26
Upgrade: Analysts Just Made A Substantial Increase To Their Molecular Partners AG (VTX:MOLN) Forecasts

We're Hopeful That Molecular Partners (VTX:MOLN) Will Use Its Cash Wisely

Jun 24
We're Hopeful That Molecular Partners (VTX:MOLN) Will Use Its Cash Wisely

Molecular Partners AG (VTX:MOLN) Could Be Less Than A Year Away From Profitability

Mar 09
Molecular Partners AG (VTX:MOLN) Could Be Less Than A Year Away From Profitability

Analysts Just Made A Major Revision To Their Molecular Partners AG (VTX:MOLN) Revenue Forecasts

Feb 10
Analysts Just Made A Major Revision To Their Molecular Partners AG (VTX:MOLN) Revenue Forecasts

Molecular Partners (VTX:MOLN) Is In A Good Position To Deliver On Growth Plans

Jan 21
Molecular Partners (VTX:MOLN) Is In A Good Position To Deliver On Growth Plans

How Much Of Molecular Partners AG (VTX:MOLN) Do Insiders Own?

Dec 17
How Much Of Molecular Partners AG (VTX:MOLN) Do Insiders Own?

Downgrade: Here's How Analysts See Molecular Partners AG (VTX:MOLN) Performing In The Near Term

Nov 21
Downgrade: Here's How Analysts See Molecular Partners AG (VTX:MOLN) Performing In The Near Term

Previsioni di crescita degli utili e dei ricavi

SWX:MOLN - Stime future degli analisti e dati finanziari passati (CHF Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/202626-72-74-402
12/31/202515-76-80-611
12/31/20245-59-64-641
6/30/20248-58-63-62N/A
3/31/20247-59-60-60N/A
12/31/20237-62-60-59N/A
9/30/20239-60-58-57N/A
6/30/20239-62-63-62N/A
3/31/202320-50-63-62N/A
12/31/2022190118117119N/A
9/30/2022189117112114N/A
6/30/2022190118111113N/A
3/31/2022182106101102N/A
12/31/202110-64-92-91N/A
9/30/20219-67-71-69N/A
6/30/20216-72-55-54N/A
3/31/20217-66-47-46N/A
12/31/20209-63-31-29N/A
9/30/202011-53-47-45N/A
6/30/202014-48-58-56N/A
3/31/202017-43-30-28N/A
12/31/201920-36-3-1N/A
9/30/201917-3701N/A
6/30/201914-3824N/A
3/31/201912-38-20-19N/A
12/31/201810-37-43-42N/A
9/30/201817-27-41-41N/A
6/30/201823-18-39-39N/A
3/31/201822-24N/AN/AN/A
12/31/201720-25N/A-40N/A
9/30/201717-26N/AN/AN/A
6/30/201716-28N/A-38N/A
3/31/201719-22N/AN/AN/A
12/31/201623-19N/A-35N/A
9/30/201627-13N/AN/AN/A
6/30/201631-3N/A18N/A
3/31/201630-2N/AN/AN/A
12/31/2015290N/A26N/A
9/30/201528-6N/AN/AN/A
6/30/201525-11N/A-24N/A
3/31/201526-5N/AN/AN/A
12/31/201427-2N/A-11N/A
12/31/2013327N/A-14N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Si prevede che MOLN rimarrà non redditizia nei prossimi 3 anni.

Guadagni vs Mercato: Si prevede che MOLN rimarrà non redditizia nei prossimi 3 anni.

Guadagni ad alta crescita: Si prevede che MOLN rimarrà non redditizia nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di MOLN ( 44.6% all'anno) crescerà più rapidamente del mercato Swiss ( 4.4% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di MOLN ( 44.6% all'anno) crescerà più rapidamente di 20% all'anno.


Previsioni di crescita dell'utile per azione


Rendimento futuro del capitale proprio

ROE futuro: Si prevede che MOLN non sarà più redditizia tra 3 anni.


Scoprire le aziende in crescita